Indivior Pharmaceuticals, Inc. (INDV) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2022: $5.00M2023: $8.00M2024: $29.00M2025: $66.00M$66.00M
2022Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$66.00M+127.6%
2024$29.00M+262.5%
2023$8.00M+60.0%
2022$5.00M